Article Details
Retrieved on: 2024-01-05 22:38:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its ...
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here